EC Number |
Inhibitors |
Structure |
---|
2.7.7.35 | more |
no inhibition by adenosine, deoxyadenosine, 3'-AMP, CMP, CDP, UDP, NADH, NAD+, ADPglucose, UDPglucose, IAA, NEM; no inhibition by NADP+, EDTA, ribose |
|
2.7.7.35 | more |
- |
|
2.7.7.35 | more |
identification of inhibitors by large-scale molecular dynamics simulations. Eight compounds show stable binding modes in the simulations, as well as favorable drug properties. The inhibitors show hydrogen bonds to Leu126, Ala154, and Ile23 |
|
2.7.7.35 | N-[(1H-benzimidazol-2-yl)methyl]-3,6-dihydrocyclopenta[c]pyrazole-3-carboxamide |
i.e. ZINC096232566, inhibitor identified by virtual screening |
|
2.7.7.35 | N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carboxamide |
i.e. ZINC079784201, inhibitor identified by virtual screening |
|
2.7.7.35 | PCMB |
ADP/phosphate-exchange, reversible by cysteine |
|
2.7.7.35 | PCMB |
ADP/phosphate-exchange and ADPribose phosphorolysis |
|
2.7.7.35 | SeO42- |
- |
|